Blood cell cancers « Advances in research and treatment while supporting and listening to the patient: the keys to recovery and quality of life » Prof Nathalie Meuleman, HEAD OF THE DEPARTMENT OF HAEMATOLOGY-ONCOLOGY at the Institut Jules Bordet. How we treat blood cell cancers The Institut Jules Bordet treats all haematological cancers, ie blood cell and lymphatic cancers. ...
Prostate cancers “Our aim is to preserve the patient’s quality of life while treating the tumour as effectively as possible.” Dr Alexandre Peltier, Urological surgeon How we treat the prostate cancers Prostate cancer is the most common cancer in men. The Institut Jules Bordet has the cutting-edge technology needed to detect and treat these tumours. ...
Head and neck cancers « Providing comprehensive care for the patient is important for our multidisciplinary team but equally important is providing it without delay ... » Delphine Talmon, Oncological Care Coordinating Nurse (ICSO) How we treat ENT cancers of the head and neck Head and neck cancers include all tumours that develop in the upper aerodigestive tract and ENT (ear, nose and throat) system: tongue, cheek, palate, nose, sinuses, salivary glands, larynx, pharynx, etc. ...
Colorectal cancers “Our philosophy is to care for patients while sparing them any pointless and difficult treatments.” Dr Alain Hendlisz, Coordinator of the Digestive Tumour CMO, Institut Bordet How we treat cancers of the colon or rectum Colorectal cancers are among the most common forms of cancer. Significant advances have been made in improving the way they are treated. Treatment requires a multidisciplinary approach. ...
Thyroid cancers “The therapeutic strategy depends largely on the risk of persistence or recurrence of the disease.” Dr Giuseppe Costante, Endocrinologist and Head of Thyroid Cancer at the EURACAN Project. How we treat thyroid cancers The Institut Jules Bordet treats all types of thyroid cancer. The great majority can be cured but require correct assessment of the risk of recurrence and follow-up care for life. ...
Gynaecological cancers How we treat gynaecological cancers The term gynaecological cancer covers cancers of the endometrium, the ovaries, the cervix, the vulva and the vagina. These intimate cancers require multidisciplinary, personalised care and treatment. Diagnosis – examinations required ...
Bone and soft tissue cancers How we treat bone and soft tissue cancers The medical team at the Institut Jules Bordet treats tumours that appear in the soft tissue (muscles, fat, nerves, blood vessels, etc), primary bone cancer in children (in close collaboration with HUDERF – the Hôpital Universitaire des Enfants Reine Fabiola) and in adults as well as bone metastases. ...
Liver cancers “A surgeon never takes the decision to operate on their own. The management of hepatic tumours is always multidisciplinary.” Dr Vincent Donckier, Hepatobiliary surgeon and head of surgery, Institut Bordet. How we treat liver cancers There are 2 types of hepatic cancer: primary liver cancer and hepatic metastases originating from other primary tumours. Surgery is the major treatment for these cancers but it is limited by the need to conserve sufficient functional liver tissue. Other therapies may be combined with surgery. ...
Urological and male genital cancers “Our patients are supported by a team of medical and paramedical specialists.” Dr Alexandre Peltier, UROLOGICAL SURGEON How we treat male urological and genital cancers Urogenital cancers are tumours that develop in the urinary or genital system. ...
Brain tumours « Neuro-Oncology is above all a multidisciplinary approach at the centre of which the quality of life of the patient is crucial » Dr Philippe Martinive Clinic Director How we treat brain tumours The Institut Jules Bordet treats both primary brain cancers and brain metastases. Medical imaging plays a major role in this treatment because, in the brain, accurate definition of the tumour is crucial. ...
Neuroendocrine tumours “A neuroendocrine tumour is a particular kind of digestive cancer that requires very specific management.” Dr Alain Hendlisz, Coordinator of the Digestive Tumour CMO, Institut Bordet. How we treat neuroendocrine tumours Although often situated in an organ of the digestive tract, neuroendocrine tumours behave differently from other digestive cancers and must often be treated in a specific way. ...
Anatomical pathology department Our role The Anatomical Pathology Department is responsible for analysing tumours sent to it by the Institut Jules Bordet, the CHU St-Pierre and the Ixelles and Molière IRIS SUD hospitals. It is a reference centre in various fields, including the diagnosis of breast, gynaecological, digestive, urogenital, pulmonary, soft tissue and head and neck cancers and lymp...
Hematology department Our role The Institut Bordet Clinical Haematology Department specialises in determining and treating diseases of the blood.The Institut Bordet is committed to the treatment of these diseases and to offering patients high-quality, individual treatment.In addition to the traditional approach to blood diseases, the Institut is also engaged in the development of innovative an...
Anaesthesiology and Intensive Care Department Our role The anaesthetist’s work is often little known but it is fundamental for optimal and safe patient care. Indeed, before anything else, it is the anaesthetist who evaluates the patient’s state of health before, during and after the operation, the surgeon essentially taking care of the intervention.Before the operation: the first evaluation is...
Oncological day hospital Our role The aim of the oncology day hospital is to avoid hospitalisation with night stays while limiting the impact of the disease and its treatments on the personal, family, social and professional life of patients with cancer. The following may be carried out in the Day Hospital:Conventional anti-cancer treatments (chemotherapy, targeted treatme...
Clinic of infectious diseases Our role The objective of the infectious diseases clinic at the Institut Jules Bordet is to prevent and treat the infectious complications occurring in cancer patients, whether they are connected with the cancer itself or with its treatment (chemotherapy, radiotherapy, surgery, etc.) ...
Internal medicine Our role The mission of the Institut Jules Bordet's Department of Internal Medicine is to assume responsibilitiy regarding:Organising, with senior doctors from other specialities, the hospital's medical activity and support for undergraduate and postgraduate students Coordinating the various sister medical specialities of internal medicine, with the exception of ...
Nuclear Medicine Our role The nuclear medicine department of the Institut Jules Bordet offers patients diagnostic tests of the functional or molecular type, as well as treatments with targeted molecular radiotherapy. The diagnostic tests differ from those carried out in the Radiology Department in that they involve the intravenous administration of substances labelled with radioactive isotope...
Medical Oncology Clinic Our role The Institut Bordet Medical Oncology Clinic has a number of roles:diagnosis and therapeutic care of patients with solid tumours overseeing administration of cancer medication for in-patients and out-patients monitoring patients during and after their treatment. The Clinic takes a multidisciplinary approach. Therapeutic decisions are made in consultation with o...
Radiotherapy Our role Radiotherapy is one of the main treatments for cancer and is used as an independent treatment or in combination with surgery and/or systemic treatment (i.e. chemotherapy). The goal is to cure cancer, to augment the prognosis, or to palliate symptoms.Radiation therapy has a biological effect on the DNA and the inflammatory status of the tumor. The side effects are decrease...